Establishing Vitreoretinal Surgery Capacity in Sierra Leone: Challenges and Opportunities to Address Retinal Health Disparities in Resource-limited Settings.
Journal
International ophthalmology clinics
ISSN: 1536-9617
Titre abrégé: Int Ophthalmol Clin
Pays: United States
ID NLM: 0374731
Informations de publication
Date de publication:
01 Oct 2024
01 Oct 2024
Historique:
medline:
31
10
2024
pubmed:
31
10
2024
entrez:
31
10
2024
Statut:
ppublish
Résumé
A range of challenges exists regarding vitreoretinal (VR) surgical services in resource-limited settings, including Sierra Leone. As a result, retinal pathologies may contribute to vision loss and blindness. In the wake of the 2013 to 2016 outbreak of Ebola virus disease in West Africa, gaps in ophthalmic care were underscored as survivors were experiencing a constellation of sequelae, including uveitis and VR disease. Given the unmet needs in addressing VR disease, systems for retinal surgical care were required. To further understand long-term ocular complications in Ebola survivors and molecular and immunologic factors associated with this, research infrastructure was developed for retinal evaluation and surgery. The 5 "S'" framework was implemented and considered staff, space, stuff, systems, and social support. The ongoing development of retinal health infrastructure has helped to address challenges related to program implementation, development of surgical capacity, and alignment with local stakeholders and collaborator objectives. VR surgical services have been established in Sierra Leone through multidisciplinary partnerships and collaboration and serve patients in-country, as well as others in West Africa who have traveled for care. Continued engagement across stakeholders can aim to address challenges and promote effective care delivery.
Identifiants
pubmed: 39480206
doi: 10.1097/IIO.0000000000000534
pii: 00004397-202406440-00006
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
31-38Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest to disclose.
Références
Yorston DB, Wood ML, Gilbert C. Retinal detachment in East Africa. Ophthalmology. 2002;109:2279–2283.
Okonkwo ON, Hassan AO, Akanbi T, et al. Vitreous hemorrhage, aetiology and visual outcome of vitrectomy in a black African population. West Afr J Med. 2022;39:958–963.
Teshome T, Melaku S, Bayu S. Pattern of retinal diseases at a teaching eye department, Addis Ababa, Ethiopia. Ethiop Med J. 2004;42:185–193.
Alter DC Retina Surgery in the Developing World. Retina Today. Accessed September 18, 2024. https://retinatoday.com/articles/2023-mar/retina-surgery-in-the-developing-world
Rice JC, Steffen J, du Toit L. Simulation training in vitreoretinal surgery: a low-cost, medium-fidelity model. Retina. 2017;37:409–412.
Peters AL. Retinal detachment in black South Africans. S Afr Med J. 1995;85:158–159.
Ally N, Ismail S, Naidu N, et al. Impact of COVID-19 on ophthalmic surgical procedures in sub-Saharan Africa: a multicentre study. Trop Med Health. 2024;52:24.
Emsley E, Steptoe PJ, Cazabon S. Management of a rhegmatogenous retinal detachment in a low-resource setting: treatment options when there is no vitreoretinal surgeon. BMJ Case Rep. 2018;2018; bcr-2017-223389. doi:10.1136/bcr-2017-223389
doi: 10.1136/bcr-2017-223389
Burton MJ, Ramke J, Marques AP, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health. 2021;9:e489–e551.
Akosman S, Tran E, Rosenberg S, et al. Patient Demand for ophthalmologists in the United States: a Google trends analysis. Ophthalmic Epidemiol. 2024;31:349–355.
World Health Organization. Universal eye health: A global action plan 2014-2019. 2013. Accessed September 18, 2024. https://www.iapb.org/wp-content/uploads/2020/09/Universal-Eye-Health_A-Global-Action-Plan-2014-2019.pdf
Strachan C, Long M, Sightsavers. End of Term Evaluation Report: Sierra Leone Eye Care Programme. 2017. Accessed September 18, 2024. https://www.iapb.org/wp-content/uploads/2020/10/SS-Sierra-Leone-Final-evaluation.pdf
World Health Organization. Sierra Leone [Country overview]. World Health Organization. Accessed July 15, 2024. https://data.who.int/countries/694
Resnikoff S, Lansingh VC, Washburn L, et al. Estimated number of ophthalmologists worldwide (International Council of Ophthalmology update): will we meet the needs? Br J Ophthalmol. 2020;104:588–592.
World Health Organization. Democratic Republic of the Congo [Country overview]. World Health Organization. Accessed July 15, 2024. https://data.who.int/countries/180
Yeh S, Shantha JG, Hayek B, et al. Clinical manifestations and pathogenesis of uveitis in ebola virus disease survivors. Ocul Immunol Inflamm. 2018;26:1128–1134.
Balendra S, Williams L, Mustapha J, et al. Clinical characteristics and aetiology of uveitis in a viral haemorrhagic fever zone. Eye (Lond). 2024;38:2110–2116.
PREVAIL III Study Group. A longitudinal study of ebola sequelae in Liberia. New Engl J Med. 2019;380:924–934.
Agua-Agum J, Allegranzi B, Ariyarajah A, et al. After Ebola in West Africa—unpredictable risks, preventable epidemics. N Engl J Med. 2016;375:587–596.
Tiffany A, Vetter P, Mattia J, et al. Ebola virus disease complications as experienced by survivors in Sierra Leone. Clin Infect Dis. 2016;62:1360–1366.
Chertow DS, Nath A, Suffredini AF, et al. Severe meningoencephalitis in a case of ebola virus disease: a case report. Ann Intern Med. 2016;165:301–304.
Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016;16:331–338.
Shantha JG, Crozier I, Hayek BR, et al. Ophthalmic manifestations and causes of vision impairment in ebola virus disease survivors in Monrovia, Liberia. Ophthalmology. 2017;124:170–177.
Berry DE, Bavinger JC, Fernandes A, et al. Posterior segment ophthalmic manifestations in ebola survivors, Sierra Leone. Ophthalmology. 2021;128:1371–1373.
Varkey JB, Shantha JG, Crozier I, et al. Persistence of ebola virus in ocular fluid during convalescence. N Engl J Med. 2015;372:2423–2427.
Zeng X, Blancett CD, Koistinen KA, et al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat Microbiol. 2017;2:17113.
Worwa G, Cooper TK, Yeh S, et al. Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey. Commun Biol. 2022;5:1204.
Davis CW, Jackson KJL, McElroy AK, et al. Longitudinal analysis of the human B cell response to Ebola virus infection. Cell. 2019;177:1566–1582.e17.
Partners in Health. PIH’s Five S’s: Essential Elements for Strong Health Systems. Partners in Health. Updated June 30, 2021. Accessed July 15, 2024. https://www.pih.org/article/pihs-five-ss-essential-elements-strong-health-systems
Ahmat A, Okoroafor SC, Kazanga I, et al. The health workforce status in the WHO African Region: findings of a cross-sectional study. BMJ Glob Health. 2022;7(suppl 1):e008317.
Lukamba RM, Yao JA, Kabesha TA, et al. Retinoblastoma in Sub-Saharan Africa: case studies of the Republic of Côte d’Ivoire and the Democratic Republic of the Congo. J Glob Oncol. 2018;4:1–8.
Nkanga ED, Nlemadim AC, Arazi M, et al. Patient-related factors and clinical management outcomes of retinoblastoma in Calabar, Nigeria. West Afr J Med. 2023;40(12 suppl 1):S36–s37.
Essuman VA, Braimah IZ, Ndanu TA, et al. Presentation of children with advanced retinoblastoma for treatment in Ghana: the caretakers’ perspectives. West Afr J Med. 2018;35:9–14.